Theraceuticals Banner

Canine Health

Chondrofocus Tablets (Small Breed)

1
Giveaway Paw

Chondrofocus acts as a nutritional aid in the prevention and management of intervertebral disc disease (ivdd) in small breed dogs.

EACH TABLET CONTAINS:

Ingredient Amount
Resveratrol 50mg
ASU (Avocado-Soybean Unsaponifiables) 40mg
MSM 30mg
Sodium Ascorbate 10mg
α -Tocopheryl Acetate 175IU
Excipients 215mg

LOADING DOSE: 1 tablet per 5kg of dog’s bodyweight. Frequency: Twice per day

Duration: For the first 10 days.

 

MAINTENANCE DOSE: 1 tablet per 5kg of dog’s bodyweight.

Frequency: Once a day. 

Duration: For as long as is clinically needed. Recommended from as young as 3 months onwards

Age Group Recommendation Rationale
< 8 Weeks Not recommended. Immature hepatic & enzymatic pathways; no safety data for resveratrol or ASU in neonates.
8–12 Weeks Use only under veterinary supervision at ½ dose if congenital spinal risk identified (e.g., chondrodystrophic breeds). Early antioxidant/chondroprotective benefit possible, but metabolism of ASU and MSM still maturing.
≥ 12 Weeks (3 Months) Safe for general use per label. All ingredients have documented tolerance in juvenile dogs beyond the weaning stage; supports early disc and cartilage resilience.
  • Evidence-based raw materials
  • Science-based dosages of Resveratrol, ASU and MSM
  • Unique Nutraceutical combination proven to prevent degeneration of intervertebral discs
  • The ultimate intervertebral disc protectant, for use in Chondrodystrophic breeds
  • Easy to dose palatable tablet formulation

100 Tablets

Giveaway Paw

Oopsie!

Someone beat you to this golden
paw today

BUT don’t worry – the fun is not over!
Complete the form below and you’ll still be entered into our draw to WIN a surprise gift!
Goodluck … paws crossed

Created by potrace 1.10, written by Peter Selinger 2001-2011
Giveaway Paw

Congratulations

Paw-Some For You!

You found the Golden Paw and you’re today’s winner! Please complete your details below and we’ll be in touch.

Created by potrace 1.10, written by Peter Selinger 2001-2011